This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Osiris Therapeutics Inc (OSIR)

NASDAQ: Health Care

Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 59.87M 24.31M 11.80M 42.40M
Cost of Sales 12.23M 6.07M 1.84M 531.00K
Gross Operating Profit 47.64M 18.24M 9.96M 41.87M
Selling, General, and Administrative Expenses 37.84M 15.53M 6.30M 7.88M
Research & Development 6.86M 4.95M 14.11M 19.16M
Operating Income before D & A (EBITDA) 2.94M -2.25M -10.44M 14.84M
Depreciation & Amortization 940.00K 587.00K 708.00K 745.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -2.05M 414.00K 49.00K 100.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -53.00K -2.42M -11.10M 14.19M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -53.00K -2.42M -11.10M 14.19M
Income Taxes 193.00K -1.33M -37.00K 43.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -246.00K -1.09M -11.06M 14.89M
Net Income From Discontinued Operations -1.54M 42.73M 0.00 0.00
Net Income From Total Operations -1.79M 41.64M -11.06M 14.89M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -1.79M 41.64M -11.06M 14.89M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-246.00K -1.09M -11.06M 14.89M
Preferred Dividends
Net Income Available To Common -246.00K -1.09M -11.06M 14.89M
Basic EPS from Continuing Ops. -0.01 -0.04 -0.34 0.45
Basic EPS from Discontinued Ops. -0.04 1.29 0.00 0.00
Basic EPS from Total Operations -0.05 1.25 -0.34 0.45
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.05 1.25 -0.34 0.45
Basic Normalized Net Income/Share -0.01 -0.04 -0.34 0.45
EPS fr Continuing Ops. -0.01 -0.04 -0.34 0.45
EPS fr Discontinued Ops -0.04 1.29 0.00 0.00
EPS fr Total Ops. -0.05 1.25 -0.34 0.45
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.05 1.25 -0.34 0.45
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.01 -0.04 -0.34 0.45
Dividends Paid per Share 0.00 0.00 0.00 0.00
OSIR News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

OSIR Osiris Therapeutics Inc

Chart of OSIR

Analysts Ratings for OSIR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
GET OSIR ANALYST REPORT

OSIR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs